Skip to main content

Leukemia, lymphoma, and myeloma.

265 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Leukemia, lymphoma, and myeloma265 studies

Acute Myeloid LeukemiaPhase 1/2NCT03214562Papers

Venetoclax

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

M.D. Anderson Cancer CenterOpen the brief

Relapsed or Refractory AML, MDS or CMMLPhase 1NCT04375631

CLAG-M or FLAG-Ida + Total Body Irradiation Before Transplant

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Fred Hutchinson Cancer CenterOpen the brief

Non Hodgkin LymphomaPhase 1NCT07225439Papers

Tafasitamab

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Paolo Caimi, MDOpen the brief

Clinical trials: Phase 1 and Phase 2, explained